1995
DOI: 10.1111/j.1365-2141.1995.tb05370.x
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune‐prone (NZW × BXSB)F1 (W/BF1) mice escape severe thrombocytopenia after treatment with deoxyspergualin, an immunosuppressant

Abstract: Male (NZW x BXSB)F1 mice spontaneously develop a disease which closely resembles human systemic autoimmune disease, involving idiopathic thrombocytopenic purpura and glomerulonephritis. We investigated whether autoimmune thrombocytopenia in the mice responded to deoxyspergualin, as immunosuppressant. Deoxyspergualin completely prevented the development of thrombocytopenia and suppressed the increase in circulating autoantibodies against platelets. This agent also ameliorated lupus nephritis. These findings sug… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 24 publications
(9 reference statements)
0
1
0
Order By: Relevance
“…Therefore, DSG may have the potential to treat successfully these most severe forms of human glomerulonephritis [21]. Also, the ability of DSG to suppress systemic lupus erythematosus (SLE)-like diseases has been demonstrated in animals and humans [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, DSG may have the potential to treat successfully these most severe forms of human glomerulonephritis [21]. Also, the ability of DSG to suppress systemic lupus erythematosus (SLE)-like diseases has been demonstrated in animals and humans [22,23].…”
Section: Introductionmentioning
confidence: 99%